• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科疫苗囤货问题。

The pediatric vaccine stockpiling problem.

机构信息

Industrial Engineering and Operations Research, Columbia University, 500 West 120th Street, New York, NY 10027, United States.

出版信息

Vaccine. 2012 Sep 21;30(43):6175-9. doi: 10.1016/j.vaccine.2012.07.066. Epub 2012 Aug 5.

DOI:10.1016/j.vaccine.2012.07.066
PMID:22874852
Abstract

The U.S. has experienced many major interruptions of its pediatric vaccine production in the past decade. The Centers for Disease Control and Prevention (CDC) copes with these shortages by building a national stockpile of pediatric vaccines, which it makes accessible to the public in the event of a shortage. The management of this stockpile is difficult due to limited production capacity and long and unpredictable production interruptions. In this paper, we address policies for managing the stockpile. We provide sufficient conditions for the optimal policy to be a modified state-dependent base-stock policy, with the base-stock level decreasing in the pipeline inventory. Since the optimal policy is in general difficult to evaluate, we derive bounds on the optimal decision in each period. We develop an efficient policy that performs on average within 1% of optimality in simulations. We show that stocking the same supply of vaccine of every type can be over-conservative in some cases, and inadequate in others by large factors. We also quantify the substantial reduction in inventory level that can be achieved when there are multiple suppliers in the market.

摘要

美国在过去十年中经历了多次儿科疫苗生产的重大中断。疾病控制与预防中心 (CDC) 通过建立国家儿科疫苗储备来应对这些短缺,以便在短缺时向公众提供疫苗。由于生产能力有限,以及生产中断时间长且不可预测,因此管理这种储备具有挑战性。在本文中,我们探讨了管理该储备的政策。我们提供了充分的条件,以使最优政策成为一种修正的状态相关基本库存政策,其中基本库存水平随管道库存而减少。由于最优政策通常难以评估,因此我们在每个时期推导出最优决策的上下界。我们开发了一种有效的策略,在模拟中平均表现优于最优策略的 1%。我们表明,在某些情况下,为每种类型的疫苗储备相同的供应可能过于保守,而在其他情况下则可能严重不足。我们还量化了当市场上有多个供应商时可以实现的库存水平的大幅降低。

相似文献

1
The pediatric vaccine stockpiling problem.儿科疫苗囤货问题。
Vaccine. 2012 Sep 21;30(43):6175-9. doi: 10.1016/j.vaccine.2012.07.066. Epub 2012 Aug 5.
2
Stockpile levels for pediatric vaccines: how much is enough?儿童疫苗的储备水平:多少才足够?
Vaccine. 2006 Apr 24;24(17):3530-7. doi: 10.1016/j.vaccine.2006.02.004. Epub 2006 Feb 20.
3
Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.建立国家儿科疫苗储备模型:供应短缺、健康影响和成本后果。
Vaccine. 2010 Aug 31;28(38):6318-32. doi: 10.1016/j.vaccine.2010.06.095. Epub 2010 Jul 16.
4
The United States pediatric vaccine stockpile program.美国儿科疫苗储备计划。
Clin Infect Dis. 2006 Mar 1;42 Suppl 3:S125-9. doi: 10.1086/499591.
5
An analysis of the pediatric vaccine supply shortage problem.儿童疫苗供应短缺问题分析
Health Care Manag Sci. 2006 Nov;9(4):371-89. doi: 10.1007/s10729-006-0001-5.
6
Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.疫苗供应问题:美国疾病控制与预防中心的观点
Clin Infect Dis. 2006 Mar 1;42 Suppl 3:S104-10. doi: 10.1086/499587.
7
Vaccine shortages: history, impact, and prospects for the future.疫苗短缺:历史、影响及未来展望
Annu Rev Public Health. 2006;27:235-59. doi: 10.1146/annurev.publhealth.27.021405.102248.
8
Factors affecting U.S. manufacturers' decisions to produce vaccines.影响美国制造商生产疫苗决策的因素。
Health Aff (Millwood). 2005 May-Jun;24(3):635-42. doi: 10.1377/hlthaff.24.3.635.
9
Response to "Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences".对《国家儿科疫苗储备的建模:供应短缺、健康影响及成本后果》的回应
Vaccine. 2011 Jan 17;29(4):615; author reply 616. doi: 10.1016/j.vaccine.2010.10.054. Epub 2010 Nov 19.
10
Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.加强美国常规接种疫苗的供应:问题与建议解决方案
Clin Infect Dis. 2006 Mar 1;42 Suppl 3:S97-103. doi: 10.1086/499585.